Hayat Pharmaceutical Industries Co. PLC (ASE:HPIC)
Jordan · Delayed Price · Currency is JOD 3.260
0.00 (0.00%)
At close: Jun 7, 2026
ASE:HPIC Income Statement
Financials in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 16.32 | 17.11 | 16.71 | 15.81 | 17.11 | 16.58 | |
Revenue Growth (YoY) | -4.03% | 2.39% | 5.72% | -7.61% | 3.15% | 0.02% |
Cost of Revenue | 6.73 | 7.05 | 7.45 | 5.93 | 6.01 | 5.39 |
Gross Profit | 9.58 | 10.06 | 9.26 | 9.88 | 11.09 | 11.19 |
Selling, General & Admin | 6.08 | 6.35 | 5.22 | 6.36 | 6.45 | 6.21 |
Research & Development | 0.91 | 0.85 | 0.7 | 0.66 | 0.58 | 0.47 |
Other Operating Expenses | -0.39 | -0.47 | -0.35 | 0.02 | -0.14 | -0.05 |
Operating Expenses | 6.98 | 7.12 | 5.57 | 7.04 | 6.89 | 6.77 |
Operating Income | 2.61 | 2.94 | 3.69 | 2.84 | 4.2 | 4.42 |
Interest Expense | -0.14 | -0.14 | -0.15 | -0.1 | -0.07 | -0.09 |
EBT Excluding Unusual Items | 2.47 | 2.81 | 3.54 | 2.74 | 4.14 | 4.33 |
Pretax Income | 2.47 | 2.81 | 3.54 | 2.74 | 4.14 | 4.33 |
Income Tax Expense | 0.45 | 0.5 | 0.45 | 0.41 | 0.61 | 0.69 |
Net Income | 2.03 | 2.31 | 3.09 | 2.33 | 3.53 | 3.64 |
Net Income to Common | 2.03 | 2.31 | 3.09 | 2.33 | 3.53 | 3.64 |
Net Income Growth | -36.74% | -25.30% | 32.73% | -34.04% | -3.12% | 3.75% |
Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 | 10 |
Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 10 | 10 |
EPS (Basic) | 0.21 | 0.24 | 0.33 | 0.25 | 0.37 | 0.38 |
EPS (Diluted) | 0.21 | 0.24 | 0.33 | 0.25 | 0.37 | 0.38 |
EPS Growth | -38.69% | -25.30% | 32.73% | -34.04% | -3.12% | 3.75% |
Free Cash Flow | 3.86 | 3.17 | 1.59 | 2.44 | 2.23 | 3.95 |
Free Cash Flow Per Share | 0.41 | 0.33 | 0.17 | 0.26 | 0.23 | 0.42 |
Dividend Per Share | 0.190 | 0.190 | 0.220 | 0.165 | 0.250 | 0.250 |
Dividend Growth | -13.64% | -13.64% | 33.33% | -34.00% | - | 25.00% |
Gross Margin | 58.74% | 58.80% | 55.40% | 62.51% | 64.85% | 67.48% |
Operating Margin | 15.98% | 17.21% | 22.09% | 17.96% | 24.58% | 26.66% |
Profit Margin | 12.42% | 13.49% | 18.49% | 14.73% | 20.63% | 21.96% |
Free Cash Flow Margin | 23.63% | 18.50% | 9.50% | 15.45% | 13.07% | 23.80% |
EBITDA | 3.83 | 4.16 | 4.79 | 3.93 | 5.26 | 5.32 |
EBITDA Margin | 23.50% | 24.33% | 28.70% | 24.84% | 30.73% | 32.09% |
D&A For EBITDA | 1.23 | 1.22 | 1.1 | 1.09 | 1.05 | 0.9 |
EBIT | 2.61 | 2.94 | 3.69 | 2.84 | 4.2 | 4.42 |
EBIT Margin | 15.98% | 17.21% | 22.09% | 17.96% | 24.58% | 26.66% |
Effective Tax Rate | 18.04% | 17.72% | 12.67% | 15.07% | 14.68% | 15.91% |